Source link : https://newshealth.biz/health-news/diabetes-drug-cuts-blood-cancer-risk/
TOPLINE: Glucagon-like peptide 1 receptor agonists (GLP-1RA) are linked to a 54% lower risk for developing hematologic cancers than insulin in patients with type 2 diabetes (T2D). The medication shows particular effectiveness in reducing risk for myelodysplastic syndromes and myeloproliferative neoplasms vs metformin. METHODOLOGY: Researchers conducted a retrospective cohort study using TriNetX, an electronic health […]
The post Diabetes Drug Cuts Blood Cancer Risk first appeared on News Health.
Author : News Health
Publish date : 2025-03-13 11:00:00
Copyright for syndicated content belongs to the linked Source.